Introducing EAACI3H: A New Era of Collaboration in Research, Innovation, and Education
Introducing EAACI3H: A New Era of Collaboration in Research, Innovation, and Education
Dear Community,
We are proud to introduce a bold and transformative new initiative from the European Academy of Allergy and Clinical Immunology (EAACI): EAACI3H – The Three Hubs.
This permanent structure marks a significant step forward in our mission to prevent and cure allergic diseases and asthma. EAACI3H is designed to strengthen the way we coordinate research, innovation, outreach, and education—bringing together science and society in the service of better health.
What is EAACI3H?
EAACI3H is built around three core hubs, each with a distinct focus but all working in synergy:
-
The Research & Innovation Hub
Driving scientific excellence by applying emerging technologies and fostering cutting-edge research. This hub also identifies and supports funding opportunities at the European level to promote impactful research that benefits clinical care and patient outcomes. -
The Public, Patients & Outreach Hub
Amplifying awareness of allergic diseases and asthma, this hub advocates for patient needs, supports public health campaigns, and helps develop clinical practice recommendations that enhance patient care. -
The Knowledge Hub
Delivering customised educational programmes for healthcare professionals at every stage of their career. This hub ensures continuous learning and professional development, grounded in the latest evidence and advancements in allergy and clinical immunology.
Why EAACI3H Matters
EAACI3H reflects our long-standing commitment to scientific progress, education, and societal impact. Through this initiative, we aim to:
-
Bridge the gap between research and real-world care, ensuring innovation reaches those who need it most.
-
Engage with patients, the public, and policymakers to raise awareness and shape better healthcare policies.
-
Empower healthcare professionals with high-quality educational resources that uphold the best standards in care and expertise.
Shaping the Future Together
EAACI3H embodies our vision of a world where allergic diseases and asthma are better understood, better managed, and, one day, fully preventable and curable. We believe this initiative will set a new benchmark in collaboration, innovation, and impact across Europe and beyond.
We thank our community, collaborators, and supporters for continuing to stand with us in this journey. Together, we can create lasting change in the lives of patients and the healthcare professionals who care for them.
Warm regards,
Prof. María José Torres
EAACI President
Prof. Mohamed Shamji
EAACI Secretary General